HEADER TRANSFERASE 12-SEP-18 6HMD TITLE STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA'; TITLE 2 CSNK2A2 GENE PRODUCT) IN COMPLEX WITH THE INDENOINDOLE-TYPE INHIBITOR TITLE 3 AR18 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE II SUBUNIT ALPHA'; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CK II ALPHA'; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK2A2, CK2A2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN KINASE CK2, CASEIN KINASE 2, CATALYTIC SUBUNIT CK2ALPHA', KEYWDS 2 CSNK2A2, INDENO[1, 2-B]INDOLE-TYPE INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR K.NIEFIND,D.LINDENBLATT,J.JOSE,M.LE BORGNE REVDAT 2 09-OCT-19 6HMD 1 JRNL REVDAT 1 27-MAR-19 6HMD 0 JRNL AUTH D.LINDENBLATT,A.NICKELSEN,V.M.APPLEGATE,J.HOCHSCHERF, JRNL AUTH 2 B.WITULSKI,Z.BOUAZIZ,C.MARMINON,M.BRETNER,M.LE BORGNE, JRNL AUTH 3 J.JOSE,K.NIEFIND JRNL TITL DIACRITIC BINDING OF AN INDENOINDOLE INHIBITOR BY CK2 ALPHA JRNL TITL 2 PARALOGS EXPLORED BY A RELIABLE PATH TO ATOMIC RESOLUTION JRNL TITL 3 CK2 ALPHA ' STRUCTURES. JRNL REF ACS OMEGA V. 4 5471 2019 JRNL REFN ESSN 2470-1343 JRNL PMID 31559376 JRNL DOI 10.1021/ACSOMEGA.8B03415 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.HOCHSCHERF,D.LINDENBLATT,B.WITULSKI,R.BIRUS,D.AICHELE, REMARK 1 AUTH 2 C.MARMINON,Z.BOUAZIZ,M.LE BORGNE,J.JOSE,K.NIEFIND REMARK 1 TITL UNEXPECTED BINDING MODE OF A POTENT INDENO[1,2-B]INDOLE-TYPE REMARK 1 TITL 2 INHIBITOR OF PROTEIN KINASE CK2 REVEALED BY COMPLEX REMARK 1 TITL 3 STRUCTURES WITH THE CATALYTIC SUBUNIT CK2ALPHA AND ITS REMARK 1 TITL 4 PARALOG CK2ALPHA' REMARK 1 REF PHARMACEUTICALS (BASEL) V. 10 2017 REMARK 1 REFN ESSN 1424-8247 REMARK 1 PMID 29236079 REMARK 1 DOI 10.3390/PH10040098 REMARK 1 REFERENCE 2 REMARK 1 AUTH I.ERMAKOVA,B.BOLDYREFF,O.G.ISSINGER,K.NIEFIND REMARK 1 TITL CRYSTAL STRUCTURE OF A C-TERMINAL DELETION MUTANT OF HUMAN REMARK 1 TITL 2 PROTEIN KINASE CK2 CATALYTIC SUBUNIT. REMARK 1 REF J. MOL. BIOL. V. 330 925 2003 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 12860116 REMARK 2 REMARK 2 RESOLUTION. 1.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.13_2998: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.33 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.960 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.2 REMARK 3 NUMBER OF REFLECTIONS : 177317 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.150 REMARK 3 R VALUE (WORKING SET) : 0.149 REMARK 3 FREE R VALUE : 0.172 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1773 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 22.3326 - 2.3504 0.92 13480 136 0.1460 0.1787 REMARK 3 2 2.3504 - 1.8659 0.96 14048 142 0.1328 0.1472 REMARK 3 3 1.8659 - 1.6301 0.95 13882 140 0.1322 0.1552 REMARK 3 4 1.6301 - 1.4811 0.95 13871 140 0.1333 0.1453 REMARK 3 5 1.4811 - 1.3750 0.94 13772 139 0.1372 0.1733 REMARK 3 6 1.3750 - 1.2939 0.93 13669 138 0.1471 0.1683 REMARK 3 7 1.2939 - 1.2291 0.93 13547 137 0.1526 0.1759 REMARK 3 8 1.2291 - 1.1756 0.92 13426 136 0.1621 0.1818 REMARK 3 9 1.1756 - 1.1304 0.91 13381 135 0.1709 0.1979 REMARK 3 10 1.1304 - 1.0913 0.90 13234 134 0.1833 0.1890 REMARK 3 11 1.0913 - 1.0572 0.90 13198 133 0.2009 0.2100 REMARK 3 12 1.0572 - 1.0270 0.89 13083 132 0.2336 0.2030 REMARK 3 13 1.0270 - 1.0000 0.89 12953 131 0.2736 0.3134 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.100 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.050 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.12 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.022 3053 REMARK 3 ANGLE : 1.317 4149 REMARK 3 CHIRALITY : 0.073 424 REMARK 3 PLANARITY : 0.006 538 REMARK 3 DIHEDRAL : 22.497 1185 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6HMD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-SEP-18. REMARK 100 THE DEPOSITION ID IS D_1200011422. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-NOV-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM30A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.920042 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 177359 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.000 REMARK 200 RESOLUTION RANGE LOW (A) : 44.880 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.2 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.04708 REMARK 200 R SYM (I) : 0.04708 REMARK 200 FOR THE DATA SET : 15.6700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.04 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 1.02800 REMARK 200 R SYM FOR SHELL (I) : 1.02800 REMARK 200 FOR SHELL : 1.360 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO PHASING REMARK 200 SOFTWARE USED: ARCIMBOLDO REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 180 MICROLITER ENZYME STOCK SOLUTION REMARK 280 (6 MG/ML IN 500 MM NACL, 25 MM TRIS/HCL, PH 8.5) WAS MIXED AND REMARK 280 INCUBATED WITH 20 MIKROLITER OF A STOCK SOLUTION OF THE REMARK 280 INHIBITOR 4B0 (10 MM 4B0 IN DMSO). 20 MICROLITERS OF THE REMARK 280 RESULTING SOLUTION WAS MIXED WITH 10 MICROLITERS OF RESERVOIR REMARK 280 SOLUTION (700 MM LICL, 28 % (W/V) PEG 6000, 100 MM TRIS/HCL, PH REMARK 280 8.5) IN EACH WELL OF A CRYSTALLIZATION PLATE. A SINGLE MACROSEED, REMARK 280 GROWN UNDER THE SAME CONDITIONS, WAS ADDED TO EACH DROPLET OF REMARK 280 THE PLATE. THE DROPLETS WERE EQUILIBRATED AT 293.15 K USING THE REMARK 280 SITTING DROP VARIANT OF THE VAPOR DIFFUSION METHOD. THIS REMARK 280 PROCEDURE GENERATED LARGE SINGLE CRYSTALS OF A CK2ALPHA'/4B0 REMARK 280 COMPLEX. AFTERWARDS, THE INHIBITOR 4B0 WAS EXCHANGED AGAINST REMARK 280 AR18 BY AN EXTENSIVE SOAKING PROCEDURE OF SEVERAL STEPS., VAPOR REMARK 280 DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13810 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A -14 REMARK 465 MET A -13 REMARK 465 GLY A -12 REMARK 465 SER A -11 REMARK 465 SER A -10 REMARK 465 HIS A -9 REMARK 465 HIS A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 SER A -3 REMARK 465 GLN A -2 REMARK 465 ASP A -1 REMARK 465 PRO A 0 REMARK 465 MET A 1 REMARK 465 PRO A 2 REMARK 465 GLY A 3 REMARK 465 PRO A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 PRO A 335 REMARK 465 SER A 336 REMARK 465 ALA A 337 REMARK 465 ASP A 338 REMARK 465 ASN A 339 REMARK 465 ALA A 340 REMARK 465 VAL A 341 REMARK 465 LEU A 342 REMARK 465 SER A 343 REMARK 465 SER A 344 REMARK 465 GLY A 345 REMARK 465 LEU A 346 REMARK 465 THR A 347 REMARK 465 ALA A 348 REMARK 465 ALA A 349 REMARK 465 ARG A 350 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HH TYR A 240 OD2 ASP A 267 1.52 REMARK 500 HZ1 LYS A 103 O HOH A 512 1.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 221 CB CYS A 221 SG -0.099 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 73 58.46 -65.64 REMARK 500 ASP A 157 42.72 -151.11 REMARK 500 ASP A 176 77.02 55.42 REMARK 500 ALA A 186 -4.18 75.78 REMARK 500 ALA A 194 175.11 59.03 REMARK 500 ALA A 194 166.69 59.03 REMARK 500 MET A 209 54.22 -93.45 REMARK 500 HIS A 235 71.60 -105.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 980 DISTANCE = 5.86 ANGSTROMS REMARK 525 HOH A 981 DISTANCE = 5.95 ANGSTROMS REMARK 525 HOH A 982 DISTANCE = 6.08 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GDW A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 404 DBREF 6HMD A 1 350 UNP P19784 CSK22_HUMAN 1 350 SEQADV 6HMD HIS A -14 UNP P19784 EXPRESSION TAG SEQADV 6HMD MET A -13 UNP P19784 EXPRESSION TAG SEQADV 6HMD GLY A -12 UNP P19784 EXPRESSION TAG SEQADV 6HMD SER A -11 UNP P19784 EXPRESSION TAG SEQADV 6HMD SER A -10 UNP P19784 EXPRESSION TAG SEQADV 6HMD HIS A -9 UNP P19784 EXPRESSION TAG SEQADV 6HMD HIS A -8 UNP P19784 EXPRESSION TAG SEQADV 6HMD HIS A -7 UNP P19784 EXPRESSION TAG SEQADV 6HMD HIS A -6 UNP P19784 EXPRESSION TAG SEQADV 6HMD HIS A -5 UNP P19784 EXPRESSION TAG SEQADV 6HMD HIS A -4 UNP P19784 EXPRESSION TAG SEQADV 6HMD SER A -3 UNP P19784 EXPRESSION TAG SEQADV 6HMD GLN A -2 UNP P19784 EXPRESSION TAG SEQADV 6HMD ASP A -1 UNP P19784 EXPRESSION TAG SEQADV 6HMD PRO A 0 UNP P19784 EXPRESSION TAG SEQADV 6HMD SER A 336 UNP P19784 CYS 336 ENGINEERED MUTATION SEQRES 1 A 365 HIS MET GLY SER SER HIS HIS HIS HIS HIS HIS SER GLN SEQRES 2 A 365 ASP PRO MET PRO GLY PRO ALA ALA GLY SER ARG ALA ARG SEQRES 3 A 365 VAL TYR ALA GLU VAL ASN SER LEU ARG SER ARG GLU TYR SEQRES 4 A 365 TRP ASP TYR GLU ALA HIS VAL PRO SER TRP GLY ASN GLN SEQRES 5 A 365 ASP ASP TYR GLN LEU VAL ARG LYS LEU GLY ARG GLY LYS SEQRES 6 A 365 TYR SER GLU VAL PHE GLU ALA ILE ASN ILE THR ASN ASN SEQRES 7 A 365 GLU ARG VAL VAL VAL LYS ILE LEU LYS PRO VAL LYS LYS SEQRES 8 A 365 LYS LYS ILE LYS ARG GLU VAL LYS ILE LEU GLU ASN LEU SEQRES 9 A 365 ARG GLY GLY THR ASN ILE ILE LYS LEU ILE ASP THR VAL SEQRES 10 A 365 LYS ASP PRO VAL SER LYS THR PRO ALA LEU VAL PHE GLU SEQRES 11 A 365 TYR ILE ASN ASN THR ASP PHE LYS GLN LEU TYR GLN ILE SEQRES 12 A 365 LEU THR ASP PHE ASP ILE ARG PHE TYR MET TYR GLU LEU SEQRES 13 A 365 LEU LYS ALA LEU ASP TYR CYS HIS SER LYS GLY ILE MET SEQRES 14 A 365 HIS ARG ASP VAL LYS PRO HIS ASN VAL MET ILE ASP HIS SEQRES 15 A 365 GLN GLN LYS LYS LEU ARG LEU ILE ASP TRP GLY LEU ALA SEQRES 16 A 365 GLU PHE TYR HIS PRO ALA GLN GLU TYR ASN VAL ARG VAL SEQRES 17 A 365 ALA SER ARG TYR PHE LYS GLY PRO GLU LEU LEU VAL ASP SEQRES 18 A 365 TYR GLN MET TYR ASP TYR SER LEU ASP MET TRP SER LEU SEQRES 19 A 365 GLY CYS MET LEU ALA SER MET ILE PHE ARG ARG GLU PRO SEQRES 20 A 365 PHE PHE HIS GLY GLN ASP ASN TYR ASP GLN LEU VAL ARG SEQRES 21 A 365 ILE ALA LYS VAL LEU GLY THR GLU GLU LEU TYR GLY TYR SEQRES 22 A 365 LEU LYS LYS TYR HIS ILE ASP LEU ASP PRO HIS PHE ASN SEQRES 23 A 365 ASP ILE LEU GLY GLN HIS SER ARG LYS ARG TRP GLU ASN SEQRES 24 A 365 PHE ILE HIS SER GLU ASN ARG HIS LEU VAL SER PRO GLU SEQRES 25 A 365 ALA LEU ASP LEU LEU ASP LYS LEU LEU ARG TYR ASP HIS SEQRES 26 A 365 GLN GLN ARG LEU THR ALA LYS GLU ALA MET GLU HIS PRO SEQRES 27 A 365 TYR PHE TYR PRO VAL VAL LYS GLU GLN SER GLN PRO SER SEQRES 28 A 365 ALA ASP ASN ALA VAL LEU SER SER GLY LEU THR ALA ALA SEQRES 29 A 365 ARG HET EDO A 401 10 HET EDO A 402 10 HET GDW A 403 49 HET CL A 404 1 HETNAM EDO 1,2-ETHANEDIOL HETNAM GDW 5-[2-(DIETHYLAMINO)ETHYL]-7,8-DIHYDRO-6~{H}-INDENO[1,2- HETNAM 2 GDW B]INDOLE-9,10-DIONE HETNAM CL CHLORIDE ION HETSYN EDO ETHYLENE GLYCOL FORMUL 2 EDO 2(C2 H6 O2) FORMUL 4 GDW C21 H24 N2 O2 FORMUL 5 CL CL 1- FORMUL 6 HOH *482(H2 O) HELIX 1 AA1 SER A 21 ASP A 26 1 6 HELIX 2 AA2 TYR A 27 HIS A 30 5 4 HELIX 3 AA3 LYS A 75 LEU A 89 1 15 HELIX 4 AA4 ASP A 121 LEU A 129 1 9 HELIX 5 AA5 THR A 130 LYS A 151 1 22 HELIX 6 AA6 LYS A 159 HIS A 161 5 3 HELIX 7 AA7 ASP A 176 ALA A 180 5 5 HELIX 8 AA8 SER A 195 LYS A 199 5 5 HELIX 9 AA9 GLY A 200 VAL A 205 1 6 HELIX 10 AB1 TYR A 212 ARG A 229 1 18 HELIX 11 AB2 ASP A 238 GLY A 251 1 14 HELIX 12 AB3 GLY A 251 TYR A 262 1 12 HELIX 13 AB4 ASP A 267 ILE A 273 5 7 HELIX 14 AB5 ARG A 281 ILE A 286 5 6 HELIX 15 AB6 ASN A 290 VAL A 294 5 5 HELIX 16 AB7 SER A 295 LEU A 306 1 12 HELIX 17 AB8 ASP A 309 ARG A 313 5 5 HELIX 18 AB9 THR A 315 HIS A 322 1 8 HELIX 19 AC1 PHE A 325 GLN A 334 1 10 SHEET 1 AA1 6 TRP A 34 ASN A 36 0 SHEET 2 AA1 6 LEU A 98 LYS A 103 1 O THR A 101 N GLY A 35 SHEET 3 AA1 6 PRO A 110 GLU A 115 -1 O VAL A 113 N ASP A 100 SHEET 4 AA1 6 ARG A 65 LEU A 71 -1 N VAL A 67 O PHE A 114 SHEET 5 AA1 6 SER A 52 ASN A 59 -1 N GLU A 53 O ILE A 70 SHEET 6 AA1 6 TYR A 40 ARG A 48 -1 N LEU A 46 O VAL A 54 SHEET 1 AA2 2 ILE A 153 MET A 154 0 SHEET 2 AA2 2 GLU A 181 PHE A 182 -1 O GLU A 181 N MET A 154 SHEET 1 AA3 2 VAL A 163 ASP A 166 0 SHEET 2 AA3 2 LYS A 171 LEU A 174 -1 O LYS A 171 N ASP A 166 CISPEP 1 GLU A 231 PRO A 232 0 -9.64 SITE 1 AC1 5 TRP A 25 HIS A 184 HOH A 582 HOH A 597 SITE 2 AC1 5 HOH A 743 SITE 1 AC2 4 ILE A 286 HIS A 287 SER A 288 ARG A 291 SITE 1 AC3 14 VAL A 54 VAL A 67 LYS A 69 ILE A 96 SITE 2 AC3 14 PHE A 114 GLU A 115 ILE A 117 HIS A 161 SITE 3 AC3 14 MET A 164 ILE A 175 ASP A 176 HOH A 532 SITE 4 AC3 14 HOH A 688 HOH A 949 SITE 1 AC4 4 ARG A 156 TYR A 189 ASN A 190 HOH A 782 CRYST1 44.890 45.820 48.520 113.02 89.21 91.18 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022277 0.000459 -0.000137 0.00000 SCALE2 0.000000 0.021829 0.009272 0.00000 SCALE3 0.000000 0.000000 0.022394 0.00000